Dimensional Fund Advisors Portfolio holdings
Dimensional Fund Advisors (DFA), founded in 1981 by David Booth and Rex Sinquefield and headquartered in Austin, Texas, is an investment management firm renowned for its evidence-based, low-cost approach to investing, grounded in academic research from Nobel laureates like Eugene Fama and Kenneth French. Managing hundreds of billions in assets, DFA focuses on systematic, passive strategies that tilt toward factors like small-cap, value, and profitability stocks, primarily through mutual funds and institutional portfolios rather than retail brokerage services. The firm’s philosophy eschews market timing and stock picking, instead emphasizing diversification and efficient market exposure, often requiring investors to access its funds through approved financial advisors. With a global presence and a reputation for disciplined, data-driven investing, DFA has carved a unique niche in the industry, blending academic rigor with practical application.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$1.61B |
| 2 |
Microsoft
MSFT
|
+$1.17B |
| 3 |
Broadcom
AVGO
|
+$366M |
| 4 |
Merck
MRK
|
+$343M |
| 5 |
Meta Platforms (Facebook)
META
|
+$260M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AstraZeneca
AZN
|
+$609M |
| 2 |
CMA
Comerica
CMA
|
+$512M |
| 3 |
CADE
Cadence Bank
CADE
|
+$422M |
| 4 |
Johnson & Johnson
JNJ
|
+$331M |
| 5 |
Western Digital
WDC
|
+$277M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.81% |
| 2 | Financials | 17.07% |
| 3 | Industrials | 12.54% |
| 4 | Consumer Discretionary | 10.14% |
| 5 | Healthcare | 9.6% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2226
Ranpak Holdings
PACK
$550M
| $10.9M | ﹤0.01% |
3,045,306
+102,942
| +3% | +$506K |
|
2227
Lennar Class B
LEN.B
$20.7B
| $10.9M | ﹤0.01% |
129,156
+2,161
| +2% | +$218K |
|
2228
Solid Power
SLDP
$475M
| $10.9M | ﹤0.01% |
3,618,519
+1,683,866
| +87% | +$6.78M |
|
2229
AngioDynamics
ANGO
$593M
| $10.8M | ﹤0.01% |
948,815
+32,476
| +4% | +$352K |
|
2230
CEVA Inc
CEVA
$883M
| $10.8M | ﹤0.01% |
575,747
+1,278
| +0.2% | +$26.8K |
|
2231
Bowman Consulting
BWMN
$463M
| $10.7M | ﹤0.01% |
377,799
+43,624
| +13% | +$1.42M |
|
2232
EverQuote
EVER
$960M
| $10.7M | ﹤0.01% |
695,716
+190,438
| +38% | +$3.6M |
|
2233
AXT Inc
AXTI
$2.8B
| $10.7M | ﹤0.01% |
187,684
| – | – |
|
2234
Fulgent Genetics
FLGT
$558M
| $10.7M | ﹤0.01% |
671,664
-217,348
| -24% | -$4.72M |
|
2235
MiMedx Group
MDXG
$649M
| $10.6M | ﹤0.01% |
2,694,002
+214,633
| +9% | +$1.08M |
|
|
FINV
2236
FinVolution Group
FINV
$1.16B
| $10.6M | ﹤0.01% |
2,220,091
+10,848
| +0.5% | +$57.5K |
|
2237
FLEX LNG
FLNG
$1.67B
| $10.6M | ﹤0.01% |
356,410
-13,589
| -4% | -$376K |
|
2238
Navitas Semiconductor
NVTS
$2.44B
| $10.6M | ﹤0.01% |
1,208,361
+715
| +0.1% | +$6.58K |
|
2239
Capital Bancorp
CBNK
$615M
| $10.6M | ﹤0.01% |
355,466
+17,264
| +5% | +$517K |
|
|
FFWM
2240
DELISTED
First Foundation Inc
FFWM
| $10.6M | ﹤0.01% |
1,789,412
-405,318
| -18% | -$2.46M |
|
2241
Velocity Financial
VEL
$698M
| $10.5M | ﹤0.01% |
582,550
+80,528
| +16% | +$1.52M |
|
2242
Hackett Group
HCKT
$266M
| $10.5M | ﹤0.01% |
809,708
-39,546
| -5% | -$632K |
|
2243
Atlanta Braves Holdings Series A
BATRA
$3.53B
| $10.5M | ﹤0.01% |
221,916
+11,392
| +5% | +$520K |
|
2244
NovoCure
NVCR
$1.89B
| $10.5M | ﹤0.01% |
960,056
+207,913
| +28% | +$2.6M |
|
2245
WPP
WPP
$4.59B
| $10.4M | ﹤0.01% |
667,869
-115,860
| -15% | -$2.18M |
|
|
SFD
2246
Smithfield Foods
SFD
$10.7B
| $10.4M | ﹤0.01% |
+371,131
| New | +$8.93M |
|
2247
Viridian Therapeutics
VRDN
$2.15B
| $10.4M | ﹤0.01% |
529,763
-25,831
| -5% | -$767K |
|
|
WSR
2248
DELISTED
Whitestone REIT
WSR
| $10.3M | ﹤0.01% |
640,742
+19,127
| +3% | +$288K |
|
2249
Hippo Holdings
HIPO
$789M
| $10.3M | ﹤0.01% |
394,907
+29,993
| +8% | +$854K |
|
2250
SAP
SAP
$209B
| $10.3M | ﹤0.01% |
60,052
-12,640
| -17% | -$2.61M |
|
Similar funds
Dimensional Fund Advisors's Q1 2026 Portfolio in Review
As of Q1 2026, Dimensional Fund Advisors held 3,312 positions worth $481B, up 0.98% from $477B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
Dimensional Fund Advisors's Q1 2026 filing shows 72 new, 1,935 increased, 1,135 reduced and 97 closed positions. Its largest new stake was Versant Media Group: 1,127,961 shares worth $41.7M. The largest sale was AstraZeneca, an estimated $609M.
By sector, the portfolio is most concentrated in Technology at 21% of assets, down from 22% a quarter earlier, followed by Financials and Industrials.
- Dimensional Fund Advisors's largest Q1 2026 buy was Versant Media Group: 1,127,961 shares worth $41.7M.
- Dimensional Fund Advisors added most to Amazon in Q1 2026, an estimated $1.61B increase.
- Dimensional Fund Advisors's biggest Q1 2026 reduction was Johnson & Johnson, cutting an estimated $331M.
- Dimensional Fund Advisors fully exited AstraZeneca in Q1 2026, selling an estimated $609M.
- Dimensional Fund Advisors's ten largest holdings make up 17% of its $481B portfolio in Q1 2026.
- Dimensional Fund Advisors opened 72 new positions and closed 97 in Q1 2026.
- Dimensional Fund Advisors's portfolio value rose 0.98% quarter-over-quarter to $481B.
Based on Dimensional Fund Advisors's 13F filing for Q1 2026, filed 7 May 2026.